Skip to content
[P]pubcas
🌐 English
EnglishEnglish简体中文Simplified Chinese繁體中文Traditional ChineseEspañolSpanishFrançaisFrenchDeutschGermanPortuguêsPortugueseРусскийRussianالعربيةArabic日本語Japanese한국어KoreanItalianoItalianNederlandsDutchPolskiPolishTürkçeTurkishTiếng ViệtVietnameseไทยThaiBahasa IndonesiaIndonesianBahasa MelayuMalayहिन्दीHindiবাংলাBengaliاردوUrduفارسیPersianעבריתHebrewУкраїнськаUkrainianRomânăRomanianČeštinaCzechSlovenčinaSlovakMagyarHungarianΕλληνικάGreekБългарскиBulgarianSvenskaSwedishDanskDanishNorsk bokmålNorwegian BokmalSuomiFinnishEestiEstonianLatviešuLatvianLietuviųLithuanianSlovenščinaSlovenianHrvatskiCroatianСрпскиSerbianBosanskiBosnianМакедонскиMacedonianShqipAlbanianAzərbaycanAzerbaijaniქართულიGeorgianՀայերենArmenianҚазақшаKazakhOʻzbekchaUzbekКыргызчаKyrgyzТоҷикӣTajikTürkmençeTurkmenМонголMongolianनेपालीNepaliසිංහලSinhalaதமிழ்TamilతెలుగుTeluguमराठीMarathiગુજરાતીGujaratiಕನ್ನಡKannadaമലയാളംMalayalamਪੰਜਾਬੀPunjabiଓଡ଼ିଆOdiaঅসমীয়াAssameseမြန်မာBurmeseខ្មែរKhmerລາວLaoFilipinoFilipinoKiswahiliSwahiliAfrikaansAfrikaansአማርኛAmharicHausaHausaYorùbáYorubaIgboIgboisiZuluZuluisiXhosaXhosaSoomaaliSomaliMalagasyMalagasyKinyarwandaKinyarwandaChiShonaShonaChichewaChichewaپښتوPashtoسنڌيSindhiKurdîKurdish KurmanjiБеларускаяBelarusianÍslenskaIcelandicGaeilgeIrishCymraegWelshMaltiMalteseEuskaraBasqueCatalàCatalanGalegoGalicianLëtzebuergeschLuxembourgishBasa JawaJavaneseBasa SundaSundaneseKreyòl ayisyenHaitian CreoleMāoriMaoriGagana SamoaSamoanLatinaLatinEsperantoEsperanto
Independent chemical reference Compare
Chemical substance record

Hydralazine

86-54-4C8H8N4160.18 g/mol

The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent. — ChEBI

Quick answers Safety references

Quick answers about Hydralazine

Identity · formula · mass

What is Hydralazine, CAS 86-54-4?

Hydralazine is the substance linked to CAS 86-54-4 in ChEBI entry CHEBI:5775. The reported formula is C8H8N4. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.

Source ↗

What is the molar mass of Hydralazine?

The ChEBI-reported molar mass is 160.18 g/mol for formula C8H8N4. Its source-reported monoisotopic mass is 160.0749 Da; that uses a specific isotope composition and is a different quantity.

Source ↗

Which PubChem properties are available for Hydralazine?

CID 3637 is connected to this record by an exact InChIKey match. PubChem reports exact mass 160.074896272 Da. computed XLogP 0.7. Values and source conventions are shown separately in the property tables below.

Source ↗

Identity & molecular properties

Source-linked values
CAS number86-54-4ChEBI ↗
Chemical formulaC8H8N4ChEBI ↗
Molar mass160.18 g/molChEBI ↗
Monoisotopic mass160.0749 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:5775ChEBI ↗

PubChem molecular properties

PubChem
Molar mass160.18 g/molPubChem ↗
Exact mass160.074896272 DaPubChem ↗
Computed XLogP0.7PubChem ↗
Topological polar surface area (Ų)63.8PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds1PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
hydralazine
1-hydrazinophthalazine
RPTUSVTUFVMDQK-UHFFFAOYSA-N
NNc1nncc2ccccc12
InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)

Names & synonyms

1-hydrazinophthalazinehidralazinahydralazinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antiatherosclerotic agenthypoglycemic agentcardiovascular drugantineoplastic agentvasodilator agentantihypertensive agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety documents & references

1 indexed references
JP · NITE

Government GHS classification

23A5072 · FY2011

View classification

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Safety classification · Japan

NITE / Japanese government
Japan · FY2011 source classification
Hydralazine · 23A5072
EndpointReported classification
Skin sensitizationCategory 1
Reproductive toxicityCategory 2
Specific target organ toxicity - Single exposureCategory 1 (cardiovascular system)
Specific target organ toxicity - Repeated exposureCategory 1 (immune system, blood)

Selected source-reported endpoints. Other endpoints, rationales and conditions remain in the original classification. Missing or unlisted information does not mean non-hazardous. This is not a global classification or transport decision.

Read the original NITE classification

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00624298 mol

Uses 160.18 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 8 atoms
59.99%
N
Nitrogen · 4 atoms
34.98%
H
Hydrogen · 8 atoms
5.03%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
US2484029 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:5775

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 3637 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.